The Pharmacy Times® Coronavirus resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Ben Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.
The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.
While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.
Today, we’re celebrating Jennifer Cardona, PharmD, who works at an independent pharmacy in Puerto Rico.
The FDA released a statement on taking action to increase US supplies to support the response to the coronavirus disease 2019 by providing instructions to manufacturers importing personal protective equipment and other devices.
The new edge-computing platform may expand the arsenal of health surveillance tools used to forecast seasonal flu and other viral respiratory outbreaks, such as COVID-19 or severe acute respiratory syndrome.
Many front-line clinicians have been investigating existing medications and repurposing them for COVID-19 treatment.
The program will award grants for training and development of educational resources for employees in high risk occupations who serve the public during emergencies and who need skills to protect their own health.
Gunda Siska, RPh, PharmD, discusses what she is doing as a hospital pharmacist to stay healthy.
Pennsylvania Governor Tom Wolf’s administration has decided that in-state and out-of-state health care providers can treat patients via telemedicine during the coronavirus disease 2019 pandemic.
Officials with the FDA have said they are beginning to see unauthorized test kits marketed for consumers to test for COVID-19 at home.
Hoth Therapeutics and Voltron Therapeutics will collaborate to develop the self-assembling vaccine technology as a means to aid patients at risk of being infected with COVID-19.